Amyotrophic Lateral Sclerosis-Like Conditions in Possible Association with Cholesterol-Lowering Drugs: An Analysis of Patient Reports to the University of California, San Diego (UCSD) Statin Effects Study

Author： Golomb Beatrice A.   Kwon Edwin K.   Koperski Sabrina   Evans Marcella A.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.32, Iss.8, 2009-08, pp. : 649-661

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statins, Neuromuscular Degenerative Disease and an Amyotrophic Lateral Sclerosis-Like Syndrome: An Analysis of Individual Case Safety Reports from Vigibase

By Edwards I. Ralph   Star Kristina   Kiuru Anne  

Drug Safety, Vol. 30, Iss. 6, 2007-01 ,pp. : 515-525

Adis International

Access to resources Recommend Favorite

Cholesterol-Lowering Drugs for Primary Prevention? The Woscop Study

By Muntoni S.  

Pharmacological Research, Vol. 35, Iss. 3, 1997-03 ,pp. : 169-170

Academic Press

Access to resources Recommend Favorite

Emerging drugs for amyotrophic lateral sclerosis

By Habib Ali Aamer   Mitsumoto Hiroshi  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 3, 2011-09 ,pp. : 537-558

Informa Healthcare

Access to resources Recommend Favorite

The preclinical discovery of amyotrophic lateral sclerosis drugs

By Glicksman Marcie A  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 11, 2011-11 ,pp. : 1127-1138

Informa Healthcare

Access to resources Recommend Favorite

Current Therapy of Drugs in Amyotrophic Lateral Sclerosis

By  

Current Neuropharmacology, Vol. 14, Iss. 4, 2016-05 ,pp. : 314-321

Bentham Science Publishers

Access to resources Recommend Favorite